PDEs for Triethylamine and for Methylisobutylketone
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 25, 2017
May 15, 2020
c3d4c7db-7f2f-4f5c-a410-e930c81766c9
Related Documents
Antiviral Product Development--Conducting and Submitting Virology Studies to the Agency: Guidance for Submitting HBV Resistance Data
Guidance DocumentJune 2, 2006Center for Drug Evaluation and Research
Antiviral Product Development--Conducting and Submitting Virology Studies to the Agency: Guidance for Submitting HCV Resistance Data
Guidance DocumentJune 2, 2006Center for Drug Evaluation and Research
Antiviral Product Development--Conducting and Submitting Virology Studies to the Agency : Guidance for Submitting Influenza Resistance Data
Guidance DocumentJune 2, 2006Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.